These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 29434212)

  • 1. CARM1-expressing ovarian cancer depends on the histone methyltransferase EZH2 activity.
    Karakashev S; Zhu H; Wu S; Yokoyama Y; Bitler BG; Park PH; Lee JH; Kossenkov AV; Gaonkar KS; Yan H; Drapkin R; Conejo-Garcia JR; Speicher DW; Ordog T; Zhang R
    Nat Commun; 2018 Feb; 9(1):631. PubMed ID: 29434212
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enhancer of zeste homolog 2 promotes the proliferation and invasion of epithelial ovarian cancer cells.
    Li H; Cai Q; Godwin AK; Zhang R
    Mol Cancer Res; 2010 Dec; 8(12):1610-8. PubMed ID: 21115743
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The histone methyltransferase EZH2 is a therapeutic target in small cell carcinoma of the ovary, hypercalcaemic type.
    Wang Y; Chen SY; Karnezis AN; Colborne S; Santos ND; Lang JD; Hendricks WP; Orlando KA; Yap D; Kommoss F; Bally MB; Morin GB; Trent JM; Weissman BE; Huntsman DG
    J Pathol; 2017 Jul; 242(3):371-383. PubMed ID: 28444909
    [TBL] [Abstract][Full Text] [Related]  

  • 4. EZH2 Inhibition Sensitizes CARM1-High, Homologous Recombination Proficient Ovarian Cancers to PARP Inhibition.
    Karakashev S; Fukumoto T; Zhao B; Lin J; Wu S; Fatkhutdinov N; Park PH; Semenova G; Jean S; Cadungog MG; Borowsky ME; Kossenkov AV; Liu Q; Zhang R
    Cancer Cell; 2020 Feb; 37(2):157-167.e6. PubMed ID: 32004442
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeting the IRE1α/XBP1s pathway suppresses CARM1-expressing ovarian cancer.
    Lin J; Liu H; Fukumoto T; Zundell J; Yan Q; Tang CA; Wu S; Zhou W; Guo D; Karakashev S; Hu CA; Sarma K; Kossenkov AV; Zhang R
    Nat Commun; 2021 Sep; 12(1):5321. PubMed ID: 34493732
    [TBL] [Abstract][Full Text] [Related]  

  • 6. NF-YA underlies EZH2 upregulation and is essential for proliferation of human epithelial ovarian cancer cells.
    Garipov A; Li H; Bitler BG; Thapa RJ; Balachandran S; Zhang R
    Mol Cancer Res; 2013 Apr; 11(4):360-9. PubMed ID: 23360797
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PRMT5 functionally associates with EZH2 to promote colorectal cancer progression through epigenetically repressing CDKN2B expression.
    Yang L; Ma DW; Cao YP; Li DZ; Zhou X; Feng JF; Bao J
    Theranostics; 2021; 11(8):3742-3759. PubMed ID: 33664859
    [No Abstract]   [Full Text] [Related]  

  • 8. The histone methyltransferase WHSC1 is regulated by EZH2 and is important for ovarian clear cell carcinoma cell proliferation.
    Kojima M; Sone K; Oda K; Hamamoto R; Kaneko S; Oki S; Kukita A; Machino H; Honjoh H; Kawata Y; Kashiyama T; Asada K; Tanikawa M; Mori-Uchino M; Tsuruga T; Nagasaka K; Matsumoto Y; Wada-Hiraike O; Osuga Y; Fujii T
    BMC Cancer; 2019 May; 19(1):455. PubMed ID: 31092221
    [TBL] [Abstract][Full Text] [Related]  

  • 9. EZH2 participates in malignant biological behavior of epithelial ovarian cancer through regulating the expression of BRCA1.
    Li T; Cai J; Ding H; Xu L; Yang Q; Wang Z
    Cancer Biol Ther; 2014 Mar; 15(3):271-8. PubMed ID: 24335192
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CARM1 methylates chromatin remodeling factor BAF155 to enhance tumor progression and metastasis.
    Wang L; Zhao Z; Meyer MB; Saha S; Yu M; Guo A; Wisinski KB; Huang W; Cai W; Pike JW; Yuan M; Ahlquist P; Xu W
    Cancer Cell; 2014 Jan; 25(1):21-36. PubMed ID: 24434208
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MicroRNA-101 inhibits growth of epithelial ovarian cancer by relieving chromatin-mediated transcriptional repression of p21(waf¹/cip¹).
    Semaan A; Qazi AM; Seward S; Chamala S; Bryant CS; Kumar S; Morris R; Steffes CP; Bouwman DL; Munkarah AR; Weaver DW; Gruber SA; Batchu RB
    Pharm Res; 2011 Dec; 28(12):3079-90. PubMed ID: 21818714
    [TBL] [Abstract][Full Text] [Related]  

  • 12. EZH2 Contributes to Anoikis Resistance and Promotes Epithelial Ovarian Cancer Peritoneal Metastasis by Regulating m6A.
    Wang SH; Liu L; Bao KY; Zhang YF; Wang WW; Du S; Jia NE; Suo S; Cai J; Guo JF; Lv G
    Curr Med Sci; 2023 Aug; 43(4):794-802. PubMed ID: 37498408
    [TBL] [Abstract][Full Text] [Related]  

  • 13. EZH2-induced H3K27me3 is associated with epigenetic repression of the ARHI tumor-suppressor gene in ovarian cancer.
    Fu Y; Chen J; Pang B; Li C; Zhao J; Shen K
    Cell Biochem Biophys; 2015 Jan; 71(1):105-12. PubMed ID: 25077680
    [TBL] [Abstract][Full Text] [Related]  

  • 14. SUZ12 promotes human epithelial ovarian cancer by suppressing apoptosis via silencing HRK.
    Li H; Cai Q; Wu H; Vathipadiekal V; Dobbin ZC; Li T; Hua X; Landen CN; Birrer MJ; Sánchez-Beato M; Zhang R
    Mol Cancer Res; 2012 Nov; 10(11):1462-72. PubMed ID: 22964433
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Methylation of EZH2 by PRMT1 regulates its stability and promotes breast cancer metastasis.
    Li Z; Wang D; Lu J; Huang B; Wang Y; Dong M; Fan D; Li H; Gao Y; Hou P; Li M; Liu H; Pan ZQ; Zheng J; Bai J
    Cell Death Differ; 2020 Dec; 27(12):3226-3242. PubMed ID: 32895488
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A hypermethylation strategy utilized by enhancer-bound CARM1 to promote estrogen receptor α-dependent transcriptional activation and breast carcinogenesis.
    Peng BL; Li WJ; Ding JC; He YH; Ran T; Xie BL; Wang ZR; Shen HF; Xiao RQ; Gao WW; Ye TY; Gao X; Liu W
    Theranostics; 2020; 10(8):3451-3473. PubMed ID: 32206101
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthetic lethality by targeting EZH2 methyltransferase activity in ARID1A-mutated cancers.
    Bitler BG; Aird KM; Garipov A; Li H; Amatangelo M; Kossenkov AV; Schultz DC; Liu Q; Shih IeM; Conejo-Garcia JR; Speicher DW; Zhang R
    Nat Med; 2015 Mar; 21(3):231-8. PubMed ID: 25686104
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacological inhibition of EZH2 using a covalent inhibitor suppresses human ovarian cancer cell migration and invasion.
    Shi L; Zhang Q; Zhu S; Tang Q; Chen X; Lan R; Wang N; Zhu Y
    Mol Cell Biochem; 2024 Apr; 479(4):831-841. PubMed ID: 37199893
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeting Fatty Acid Reprogramming Suppresses CARM1-expressing Ovarian Cancer.
    Lombardi S; Goldman AR; Tang HY; Kossenkov AV; Liu H; Zhou W; Herlyn M; Lin J; Zhang R
    Cancer Res Commun; 2023 Jun; 3(6):1067-1077. PubMed ID: 37377614
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Three-dimensional culture sensitizes epithelial ovarian cancer cells to EZH2 methyltransferase inhibition.
    Amatangelo MD; Garipov A; Li H; Conejo-Garcia JR; Speicher DW; Zhang R
    Cell Cycle; 2013 Jul; 12(13):2113-9. PubMed ID: 23759589
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.